Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
This study investigates the poor reversibility of salmon calcitonin (sCT) binding to rat and human calcitonin receptors. Efficacy of CT and analogue peptides in (125)I-sCT binding competition and cAMP assays was compared with the dissociation kinetics of (125)I-labelled peptides. Assessment was performed on cells stably expressing either rat or human calcitonin receptors. Dissociation kinetics of the antagonists, sCT(8-32) and AC512, revealed that binding was rapidly and completely reversible at the receptors, despite high affinity binding, suggesting that poor reversibility required the active conformation of the receptor. G protein coupling was not essential as the dissociation kinetics of (125)I-sCT binding to cell membranes did not significantly alter in the presence of GTP gamma S. Time course experiments established that the transition to irreversibility was slow, while the reversible component of binding appeared to involve a single population of either receptor states or binding sites. Pre-bound (125)I-human CT dissociated rapidly from the receptors, indicating that not all agonists bound irreversibly. To identify structural features of sCT that contribute to its poor reversibility, dissociation kinetics of sCT analogues with various structural modifications were examined. Increasing truncation of N-terminal residues of sCT analogues led to a corresponding increase in the rate of peptide dissociation. Salmon CT peptides which had been substituted at the N-terminus by 13-21 residues of human CT (hCT) were equipotent with sCT in binding competition and cAMP accumulation assays but exhibited a dissociation rate similar to hCT. In contrast, despite lower affinity and efficacy at the receptors, the chimeric analogue sCT(1-16)-hCT(17-32) displayed poorly reversible binding, similar to sCT. Analysis of the dissociation kinetics of sCT analogues with differing alpha-helix forming potential indicated that the ability to form alpha-helical secondary structure was an important factor in the rate of ligand dissociation. We hypothesise that poor reversibility results from a conformational change in the receptor and/or ligand and that this is dependent, at least in part, on interaction with residues constrained within the alpha-helix of the peptide.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In structure/function studies, chimeras of sCT and hCT were made, and sCT peptides, which had the NH 2 terminus substituted by the 13-21 residues of hCT, completely dissociated from receptors, whereas combinations of sCT (1-16) and hCT (17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32) retained the irreversible binding of sCT (92).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [92]
Citations
Cites
Biochemical and Biophysical Research Communications
(1960) · Nature · doi:10.1038/186124d0 · Cited by 6,700
Nicholson, G. C., Moseley, J. M., Sexton, P. M., Mendelsohn, F. A., & Martin, T. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112584 · Cited by 454 · cited 3×
“…of sCT, sCT analogues and sCT/hCT chimeras Synthetic sCT, sCT analogues and sCT/hCT chimeric peptides were iodinated as previously described (Nicholson et al. 1986), with 125I using 5 µg chloramine T for 10 s as oxidant, purification with the silica resin QUSO G32 (North America Silica Co.,…”
BackgroundMethodInfluentialSelf-citationGorn, A. H., Lin, H. Y., Yamin, M., Auron, P. E., Flannery, M. R., Tapp, D. R., Manning, C. A., Lodish, H. F., Krane, S. M., & Goldring, S. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116046 · Cited by 211 · cited 4×
“Calcitonin receptors (CTRs) have been cloned from a number of species including rat (Sexton et al. 1993) and human (Gorn et al. 1992, Kuestner et al. 1994).”
BackgroundMethodInfluentialBisello, A., Adams, A. E., Mierke, D. F., Pellegrini, M., Rosenblatt, M., Suva, L. J., & Chorev, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22498 · Cited by 181 · cited 1×
“It has been speculated that the -helical secondary structure adopted by family B G protein coupled receptor ligands may be important in orienting the ligand into phase with the binding site(s) of the receptor (Bisello et al. 1998).”
BackgroundFull Activation of Chimeric Receptors by Hybrids between Parathyroid Hormone and Calcitonin
Bergwitz, C., Gardella, T. J., Flannery, M. R., Potts, J. T., Kronenberg, H. M., Goldring, S. R., & Jüppner, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26469 · Cited by 169 · cited 1×
“Chimeric peptide/receptor studies between sCT and PTH and their receptors, have revealed a similar mode of ligand–receptor interaction for these peptides (Bergwitz et al. 1996).”
BackgroundCloning and characterization of an abundant subtype of the human calcitonin receptor.
Kuestner, R. E., Elrod, R. D., Grant, F. J., Hagen, F. S., Kuijper, J. L., Matthewes, S. L., O'Hara, P. J., Sheppard, P. O., Stroop, S. D., & Thompson, D. L. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09678-6 · Cited by 149 · cited 7×
“G protein coupling was not essential as the dissociation kinetics of 125I-sCT binding to cell membranes did not significantly alter in the presence of GTP S. Time course experiments established that the transition to irreversibility was slow, while the reversible component of binding appeared to…”
BackgroundMethodInfluentialIdentification of brain isoforms of the rat calcitonin receptor.
Sexton, P. M., Houssami, S., Hilton, J. M., O'Keeffe, L. M., Center, R. J., Gillespie, M. T., Darcy, P., & Findlay, D. M. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.6.8395656 · Cited by 134 · cited 3×
“In rat, the principle receptor isoforms, C1a and C1b, differ by the absence or presence, respectively, of a 37 amino acid insert in the predicted second extracellular domain (Sexton et al. 1993).”
BackgroundSelf-citationCharacterization and regional distribution of calcitonin binding sites in the rat brain
Fischer, J. A., Sagar, S. M., & Martin, J. B. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90018-7 · Cited by 107 · cited 4×
“This is true of human or rat tissue membrane preparations ( Fischer et al. 1981, Nicholson et al. 1988b), as well as clonal cell lines of rat or human origin (Findlay et al. 1981, Chao & Forte 1983).”
BackgroundResultInfluentialOffermanns, S. (1996) · Molecular Endocrinology · doi:10.1210/me.10.5.566 · Cited by 106 · cited 2×
“This is particularly true for release of intracellular calcium, presumably mediated by coupling to Gq (Offermanns et al. 1996), as no signal was seen in insert-positive receptor (Moore et al.”
BackgroundMoore, E. E. (1995) · Molecular Endocrinology · doi:10.1210/me.9.8.959 · Cited by 104 · cited 9×
“Analysis of the function of the I1 insert demonstrates that while ligand recognition remains essentially unchanged, G protein-mediated signalling is markedly impaired (Moore et al. 1995).”
BackgroundMethodInfluentialSelf-citation
Cited by
Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804
“Although 125I-human CT binds reversibly to its receptor, salmon CT binds irreversibly, resulting in sustained cAMP accumulation (Fischer et al., 1981; Nicholson et al., 1987; Hilton et al., 2000).”
BackgroundSelf-citationPhase-plate cryo-EM structure of a class B GPCR–G-protein complex
Liang, Y.-L., Khoshouei, M., Radjainia, M., Zhang, Y., Glukhova, A., Tarrasch, J., Thal, D. M., Furness, S. G. B., Christopoulos, G., Coudrat, T., et al. (2017) · Nature · doi:10.1038/nature22327 · Cited by 462
“Nonspecific binding was measured in the presence of 1 μM of [8-32]sCT.”
BackgroundMethodSelf-citationAmylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400
“This is not surprising, given that it contains portions of the salmon calcitonin sequence; salmon calcitonin is well recognized as having a slow receptor dissociation rate from receptors (Hilton et al., 2000).”
BackgroundAdvances in therapeutic peptides targeting G protein-coupled receptors
Davenport, A. P., Scully, C. C. G., de Graaf, C., Brown, A. J. H., & Maguire, J. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0062-z · Cited by 275
Dean, T., Vilardaga, J.-P., Potts, J. T., & Gardella, T. J. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0274 · Cited by 227
“Thus, several others of these receptors, including the receptors for calcitonin (34), CRH (17), and glucagon (35) have been shown to form a stable complex with their cognate peptide ligand in the presence of a nonhydrolyzable guanine nucleotide analog.”
BackgroundThe Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
“In structure/function studies, chimeras of sCT and hCT were made, and sCT peptides, which had the NH2 terminus substituted by the 13–21 residues of hCT, completely dissociated from receptors, whereas combinations of sCT (1–16) and hCT (17–32) retained the irreversible binding of sCT (92).”
BackgroundKarsdal, M. A., Henriksen, K., Leeming, D. J., Mitchell, P., Duffin, K., Barascuk, N., Klickstein, L., Aggarwal, P., Nemirovskiy, O., Byrjalsen, I., et al. (2009) · Biomarkers · doi:10.1080/13547500902777608 · Cited by 135
“Studies have shown that binding of calcitonin to its receptor activates the cAMP–protein kinase A and the Ca2+–protein kinase C signalling pathways (Sexton et al. 1999, Purdue et al. 2002, Hilton et al. 2000).”
BackgroundLigand-Dependent Modulation of G Protein Conformation Alters Drug Efficacy
Furness, S. G. B., Liang, Y.-L., Nowell, C. J., Halls, M. L., Wookey, P. J., Dal Maso, E., Inoue, A., Christopoulos, A., Wootten, D., & Sexton, P. M. (2016) · Cell · doi:10.1016/j.cell.2016.09.021 · Cited by 134
“As expected, wild-type sCT had a very slow off rate (Andreassen et al., 2014; Hilton et al., 2000), with a T1/2 of >40 min, whereas all chimeric peptides displayed significantly faster off rate kinetics (Figures 4D–4I), demonstrating that observed potencies in the cAMP assay are not correlated with…”
InfluentialSelf-citationMolecular Pharmacology of the Calcitonin Receptor
Purdue, B. W., Tilakaratne, N., & Sexton, P. M. (2002) · Receptors and Channels · doi:10.1080/10606820213681 · Cited by 113
Self-citationAllostery and biased agonism at class B G protein-coupled receptors
Wootten, D., Miller, L. J., Koole, C., Christopoulos, A., & Sexton, P. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00049 · Cited by 112
Self-citationBower, R. L., & Hay, D. L. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13496 · Cited by 104
“This effect is likely to be attributable to the sCT sequence within the peptide, where the degree of helical secondary structure in sCT appears to influence peptide binding kinetics (Hilton et al., 2000).”
BackgroundA structural basis for amylin receptor phenotype
Cao, J., Belousoff, M. J., Liang, Y.-L., Johnson, R. M., Josephs, T. M., Fletcher, M. M., Christopoulos, A., Hay, D. L., Danev, R., Wootten, D. L., et al. (2022) · Science · doi:10.1126/science.abm9609 · Cited by 99
“The persistent binding of sCT requires formation of an active conformation and is associated with prolonged signaling, but the transition to pseudoirreversible binding occurs slowly at the population level (39), suggesting that this state is infrequently sampled.”
BackgroundMethodSelf-citationProlonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias
Andreassen, K. V., Hjuler, S. T., Furness, S. G., Sexton, P. M., Christopoulos, A., Nosjean, O., Karsdal, M. A., & Henriksen, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092042 · Cited by 89
“3610(29) M (Figure 1E), confirming the expected difference in affinity between hCT and sCT under these experimental conditions [12,19].”
BackgroundResultInfluentialSelf-citationKarsdal, M. A., Henriksen, K., Bay-Jensen, A. C., Molloy, B., Arnold, M., John, M. R., Byrjalsen, I., Azria, M., Riis, B. J., Qvist, P., et al. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010372625 · Cited by 87
Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin
Bower, R. L., Yule, L., Rees, T. A., Deganutti, G., Hendrikse, E. R., Harris, P. W. R., Kowalczyk, R., Ridgway, Z., Wong, A. G., Swierkula, K., et al. (2018) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00002 · Cited by 80
Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat
Mathiesen, D. S., Lund, A., Vilsbøll, T., Knop, F. K., & Bagger, J. I. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.617400 · Cited by 86
“The prolonged duration is likely explained by slow receptor disassociation of the salmon calcitonin portion of davalintide (38, 127).”
BackgroundCalcitonin and Amylin Receptor Peptide Interaction Mechanisms
Lee, S. M., Hay, D. L., & Pioszak, A. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.713628 · Cited by 79
“binding to the human receptor (15) and the ability of exogenous CT to affect bone turnover (16).”
BackgroundCalcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
New Insights into the Structure and Function of Class B1 GPCRs
Cary, B. P., Zhang, X., Cao, J., Johnson, R. M., Piper, S. J., Gerrard, E. J., Wootten, D. L., & Sexton, P. M. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac033 · Cited by 77
Self-citationAndreassen, K. V., Feigh, M., Hjuler, S. T., Gydesen, S., Henriksen, J. E., Beck-Nielsen, H., Christiansen, C., Karsdal, M. A., & Henriksen, K. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00121.2014 · Cited by 70
Dean, T., Linglart, A., Mahon, M. J., Bastepe, M., Jüppner, H., Potts, J. T. J., & Gardella, T. J. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0349 · Cited by 71
“The molecular nature of this putative GTP S-insensitive, high-affinity ligand-receptor state (R) is unclear, but it is intriguing to consider the possibility that the capacity for its formation is a general property of the class 2 GPCRs, and that it might play some role in the biological activities of these receptors,…”
BackgroundFletcher, M. M., Keov, P., Truong, T. T., Mennen, G., Hick, C. A., Zhao, P., Furness, S. G. B., Kruse, T., Clausen, T. R., Wootten, D., et al. (2021) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000567 · Cited by 68
“As has been previously reported, hCT and rAmy also had short residency times (Hilton et al., 2000; Furness et al., 2016), and this was also true of the amylin analog AM1213.”
BackgroundResultSelf-citationEffects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats
Reidelberger, R. D., Kelsey, L., & Heimann, D. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00597.2001 · Cited by 70
“Recent evidence suggests that the two cloned receptors , the CT receptor (CTR) and the CT receptor-like receptor (CRLR), form the basis of all receptors for sCT, amylin, CGRP, CT, and ADM (42).”
BackgroundInfluentialBello, N. T., Kemm, M. H., Ofeldt, E. M., & Moran, T. H. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00275.2010 · Cited by 66
“This compound irreversibly binds to amylin receptors to produce sustained anorectic responses (15).”
BackgroundKarsdal, M. A., Sumer, E. U., Wulf, H., Madsen, S. H., Christiansen, C., Fosang, A. J., & Sondergaard, B. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22599 · Cited by 67
Calcitonin is involved in cartilage homeostasis: Is calcitonin a treatment for OA?
Karsdal, M. A., Tankó, L. B., Riis, B. J., Søndergaard, B. C., Henriksen, K., Altman, R. D., Qvist, P., & Christiansen, C. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.03.014 · Cited by 64
Qi, T., Dong, M., Watkins, H., Wootten, D., Miller, L., & Hay, D. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02197.x · Cited by 47
“This apparently contradicts the full-length sCT data but sCT is a very potent/ high affinity agonist that elicits poor reversibility of binding to human CTR; on the other hand, antagonists including CT8–32 bind reversibly to the receptor (Hilton et al., 2000; Poyner et al., 2002).”
BackgroundThe Molecular Control of Calcitonin Receptor Signaling
Maso, E. D., Glukhova, A., Zhu, Y., García‐Nafría, J., Tate, C. G., Atanasio, S., Reynolds, C. A., Ramírez-Aportela, E., Carazo, J. M., Hick, C. A., et al. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00056 · Cited by 48
Self-citationCalcitonin receptor isoforms expressed in the developing rat kidney
Tikellis, C., Xuereb, L., CASLEY, D. J., Brasier, G., Cooper, M. E., & Wookey, P. J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00754.x · Cited by 42
Pham, V., Wade, J. D., Purdue, B. W., & Sexton, P. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307214200 · Cited by 40
Self-citationShort amylin receptor antagonist peptides improve memory deficits in Alzheimer’s disease mouse model
Soudy, R., Kimura, R., Patel, A., Fu, W., Kaur, K., Westaway, D. A., Yang, J., & Jhamandas, J. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-47255-9 · Cited by 40
Zakariassen, H. L., John, L. M., & Lutz, T. A. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13427 · Cited by 37
“Salmon calcitonin also displays a long residence time on the CTR, binding irreversibly [76, 77] and inducing long-lasting intracellular cAMP signalling in vitro [78].”
BackgroundSalmon calcitonin distributes into the arcuate nucleus to a subset of NPY neurons in mice
Zakariassen, H. L., John, L. M., Lykkesfeldt, J., Raun, K., Glendorf, T., Schaffer, L., Lundh, S., Secher, A., Lutz, T. A., & Le Foll, C. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107987 · Cited by 33
Calcitonin-derived peptide carriers: Mechanisms and application
Rennert, R. C., Neundorf, I., & Beck‐Sickinger, A. G. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.008 · Cited by 35
Bailey, R. J., & Hay, D. L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707246 · Cited by 35
“Salmon calcitonin is known to bind essentially irreversibly to calcitonin receptors (Hilton et al., 2000) and this causes persistent activation of cAMP (Michelangeli et al., 1983).”
BackgroundKazantzis, A., Waldner, M., Taylor, J. W., & Kapurniotu, A. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02689.x · Cited by 33
Hamdy, R. C., & Daley (2012) · International Journal of Women s Health · doi:10.2147/ijwh.s24776 · Cited by 43
Maso, E. D., Zhu, Y., Pham, V., Reynolds, C. A., Deganutti, G., Hick, C. A., Yang, D., Christopoulos, A., Hay, D. L., Wang, M.-W., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.005 · Cited by 30
“[9,47] that likely constrains the location of the N-terminus to maintain interactions, whereas the additional constraints imposed by the disulphide bridge are required to facilitate interactions for hCT.”
BackgroundResultSelf-citationMaso, E. D., Just, R., Hick, C. A., Christopoulos, A., Sexton, P. M., Wootten, D. L., & Furness, S. G. B. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.016 · Cited by 29
Self-citationPham, V., & Sexton, P. M. (2003) · Journal of Peptide Science · doi:10.1002/psc.541 · Cited by 25
Self-citationTHERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin – physiology and pharmacology
Mathiesen, D. S., Lund, A., Holst, J. J., Knop, F. K., Lutz, T. A., & Bagger, J. I. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1261 · Cited by 23
Distributed amylin receptor signaling and its influence on motivated behavior
Kern, K. A., & Mietlicki‐Baase, E. G. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112958 · Cited by 20
Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys
Bello, N. T., Kemm, M. H., & Moran, T. H. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90327.2008 · Cited by 19
Boccia, L., Borner, T., Ghidewon, M. Y., Kulka, P., Piffaretti, C., Doebley, S. A., Jonghe, B. C. D., Grill, H. J., Lutz, T. A., & Foll, C. L. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101444 · Cited by 18
“com compared to amylin, which is considered the reason for its longer and more potent hypophagic effect [1,12,14,15,16,17].”
BackgroundBoccia, L., Foll, C. L., & Lutz, T. A. (2020) · The FASEB Journal · doi:10.1096/fj.202001456rrr · Cited by 17
Taylor, J. W., Jin, Q. K., Sbacchi, M., Wang, L., Belfiore, P., Garnier, M. J., Kazantzis, A., Kapurniotu, A., Zaratin, P., & Scheideler, M. A. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010474o · Cited by 14
Yoshimura, T., Akitoshi, I. T. O., Saito, S., Takeda, M., Kuriyama, H., & Ishikawa, T. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.00934.x · Cited by 13
Varshosaz, J., Minaiyan, M., & Forghanian, M. (2014) · BioMed Research International · doi:10.1155/2014/932615 · Cited by 12
Lee, S.-M., Hay, D. L., & Pioszak, A. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.a115.713628 · Cited by 21
“2 μM IC50 and bound hαCGRP(8-37), rAmy(837), AC187, and pramlintide(8-37) with IC50 values in the range of 10 μM to 44 μM; relative to sCT(8-32) these values indicated stronger binding to RAMP1-CTR than CTR alone (Fig.”
BackgroundMethodInfluentialGiansanti, M., Gabrieli, A. D., Prete, S. P., Ottone, T., Divona, M. D., Karimi, T., Ciccarone, F., Voso, M. T., Graziani, G., & Faraoni, I. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000537 · Cited by 12
Abdelmagid, N., Bereczky-Veress, B., Guerreiro‐Cacais, A. O., Bergman, P., Luhr, K. M., Bergström, T. B., Sköldenberg, B., Piehl, F., Olsson, T. P., & Diez, M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002753 · Cited by 10
“antagonist [16], into the whiskers area prior to the infection.”
BackgroundCalcitonin-Induced Effects on Amniotic Fluid-Derived Mesenchymal Stem Cells
Morabito, C., D’Alimonte, I., Pierdomenico, L., Pipino, C., Guarnieri, S., Caprara, G. A., Antonucci, I., Ciccarelli, R., Marchisio, M., Pandolfi, A., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374069 · Cited by 10
Nashawi, H., Gustafson, T. J., & Mietlicki‐Baase, E. G. (2020) · Experimental Physiology · doi:10.1113/ep088356 · Cited by 9
When two keys fit one lock, surprises follow
Rosenblatt, M. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.225 · Cited by 7
Calcitonin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Hay, D. L., Poyner, D. R., & Walker, C. S. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2019.4 · Cited by 6
Babin, K. M., Kılınç, C., Gostynska, S. E., Dickson, A., & Pioszak, A. A. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00812 · Cited by 5
Peripheral Pathways in the Food-Intake Control towards the Adipose-Intestinal Missing Link
Zerón, H. M., García, M. V. D., Romero, M. D. S. C., & Flores‐Merino, M. V. (2013) · International Journal of Endocrinology · doi:10.1155/2013/598203 · Cited by 6
“This compound irreversibly binds to amylin receptors to produce sustained anorectic responses [13].”
BackgroundWhere are we now? Biased signalling of Class B G protein-coupled receptor-targeted therapeutics
Tasma, Z., Garelja, M. L., Jamaluddin, A., Alexander, T. I., & Rees, T. A. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108846 · Cited by 4
Suzuki, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820649-2.00105-4 · Cited by 4
Modulation of amylin and calcitonin receptor activation by hybrid peptides
Lee, S. M. (2024) · Peptides · doi:10.1016/j.peptides.2024.171314 · Cited by 3
Dimers of G-Protein Coupled Receptors as Versatile Storage and Response Units
Parker, M. S., Sah, R., Balasubramaniam, A., Park, E., Sallee, F. R., & Parker, S. L. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034856 · Cited by 3
“Such stable (“quasi-irreversible”) binding was found for endothelin at endothelin-1 receptor [46], salmon calcitonin at the human calcitonin receptor [47], pancreatic polypeptide at the Y4 receptor [48], neuromedin U at its receptors [49], NPY at the Y2 receptor [50], PYY(3-36) also at the Y2 receptor [16], and NPY (b…”
BackgroundDevelopment of a Hyperglycemic Fish Model and Analysis of Bone Metabolism
Kuroda, K., Tabuchi, Y., Takino, H., Maruyama, Y., Honda, M., Matsubara, H., Hirayama, J., Hattori, A., & Suzuki, N. (2025) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b25-00316 · Cited by 2
Suzuki, N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801028-0.00170-7 · Cited by 2
Kinetics of Drug-Target Binding: A Guide for Drug Discovery
Hoare, S. R. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00011-6 · Cited by 3
Yao, M., & Abel, P. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.92834-4 · Cited by 2
Calcitonin receptors in GtoPdb v.2021.2
Hay, D. L., Poyner, D. R., & Walker, C. S. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2021.2 · Cited by 1
Acetyl-[Asn30,Tyr32]-calcitonin fragment 8-32 forms channels in phospholipid planar lipid membranes
Meleleo, D., Gallucci, E., Picciarelli, V., & Micelli, S. (2007) · European Biophysics Journal · doi:10.1007/s00249-007-0150-6 · Cited by 1
“2000) and of the wild type hormone because they stabilize the receptors in an inactive state (Beaumont et al. 1995a, b; Pozvek et al. 1997; Disa et al. 1998; Hilton et al. 2000; Pham et al. 2005; Young et al. 1994; Young 1995; Harris et al. 1997).”
BackgroundThe influence of calcitonin on the liver secretory function in rats
Horenko, Z., Karabovs'ka, L., Vasheka, I., & Vesel'skyĭ, S. (2011) · Fìzìologìčnij žurnal · doi:10.15407/fz57.03.040
Smith, D. D. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.63830-9
Smith, D. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.96809-0 · Cited by 1
Yao, M., & Abel, P. W. (2008) · Elsevier eBooks · doi:10.1016/b978-008055232-3.63173-3
Metadata
- Authors
- Hilton, J., Dowton, M., Houssami, S., & Sexton, P.
- Affiliations
- The University of Melbourne (AU)
- ORCID
- Dowton, M
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2000-07-01
- Volume
- 166
- Issue
- 1
- Pages
- 213-226
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2134691383
- Cited by
- 70
- References
- 42
- Citations by year
- 2025: 3 · 2024: 1 · 2022: 4 · 2021: 6 · 2020: 7 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 4 · 2013: 1 · 2012: 3
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amylin Pharmaceuticals
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- salmon calcitonin, calcitonin receptor, ligand dissociation kinetics, receptor conformational change, N-terminal truncation, alpha-helix, G protein coupling
- MeSH terms
- Cyclic AMP, Animals, Binding, Competitive, Calcitonin, Cells, Cultured, Humans, Protein Binding, Receptors, Calcitonin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.